PetIQ Inc (PETQ)
30.98
0.00 (0.00%)
USD |
NASDAQ |
Oct 25, 16:00
PetIQ Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 25, 2024 | 1.280B |
| October 24, 2024 | 1.280B |
| October 23, 2024 | 1.280B |
| October 22, 2024 | 1.280B |
| October 21, 2024 | 1.280B |
| October 18, 2024 | 1.278B |
| October 17, 2024 | 1.278B |
| October 16, 2024 | 1.277B |
| October 15, 2024 | 1.277B |
| October 14, 2024 | 1.277B |
| October 11, 2024 | 1.277B |
| October 10, 2024 | 1.277B |
| October 09, 2024 | 1.276B |
| October 08, 2024 | 1.276B |
| October 07, 2024 | 1.277B |
| October 04, 2024 | 1.277B |
| October 03, 2024 | 1.276B |
| October 02, 2024 | 1.275B |
| October 01, 2024 | 1.274B |
| September 30, 2024 | 1.274B |
| September 27, 2024 | 1.273B |
| September 26, 2024 | 1.273B |
| September 25, 2024 | 1.273B |
| September 24, 2024 | 1.273B |
| September 23, 2024 | 1.274B |
| Date | Value |
|---|---|
| September 20, 2024 | 1.273B |
| September 19, 2024 | 1.273B |
| September 18, 2024 | 1.274B |
| September 17, 2024 | 1.273B |
| September 16, 2024 | 1.272B |
| September 13, 2024 | 1.271B |
| September 12, 2024 | 1.270B |
| September 11, 2024 | 1.270B |
| September 10, 2024 | 1.271B |
| September 09, 2024 | 1.271B |
| September 06, 2024 | 1.267B |
| September 05, 2024 | 1.268B |
| September 04, 2024 | 1.266B |
| September 03, 2024 | 1.267B |
| August 30, 2024 | 1.267B |
| August 29, 2024 | 1.266B |
| August 28, 2024 | 1.265B |
| August 27, 2024 | 1.266B |
| August 26, 2024 | 1.266B |
| August 23, 2024 | 1.266B |
| August 22, 2024 | 1.265B |
| August 21, 2024 | 1.265B |
| August 20, 2024 | 1.266B |
| August 19, 2024 | 1.267B |
| August 16, 2024 | 1.268B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
598.23M
Minimum
Oct 10 2022
1.722B
Maximum
Apr 27 2021
1.010B
Average
976.51M
Median
Enterprise Value Benchmarks
| Omeros Corp | 268.91M |
| BioCardia Inc | 3.655M |
| Revance Therapeutics Inc | 802.59M |
| Zevra Therapeutics Inc | 451.06M |
| Alector Inc | -14.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 15.32M |
| Revenue (Quarterly) | 328.94M |
| Total Expenses (Quarterly) | 300.74M |
| EPS Diluted (Quarterly) | 0.49 |
| Gross Profit Margin (Quarterly) | 26.84% |
| Profit Margin (Quarterly) | 4.66% |